Bloomberg: The Mysterious Billionaire Behind the World's Most Popular Vapes (Heaven Gifts)

Mar.05.2025
Bloomberg: The Mysterious Billionaire Behind the World's Most Popular Vapes (Heaven Gifts)
Bloomberg's report on March 4 reveals the success story of Heaven Gifts in becoming the world's top e-cigarette brand.

Statement:

1. All information in this article is sourced from Bloomberg reports. The facts and data listed in the article only represent the views of the original author.

2. The author of the Bloomberg article reached out to 2Firsts for an interview on the relevant issues. However, Alan Zhao, the founder and CEO of 2Firsts, declined to provide commentary on any specific individuals, instead offering a written analysis on the industry-level aspects such as product categories and compliance.


 

On March 4th, Bloomberg published an article titled "The Mysterious Billionaire Behind the World's Most Popular Vapes," detailing how Heaven Gifts and its controlling shareholder transformed their e-cigarette business from a small online shop into a global industry worth billions of dollars. 

 

The article mentioned that Heaven Gifts started as an online store and gradually became a prominent player in the e-cigarette industry, introducing brands like Geekvape, Lost Mary, and Elf Bar, which have captured markets worldwide. According to the Bloomberg Billionaires Index, the controlling shareholder's net worth is estimated to be $2.9 billion, and his core company, iMiracle Shenzhen Technologies Ltd., has 30 million customers in over 80 countries. (Original text: Heaven Gifts has at least 30 million customers in more than 80 countries, and a survey of US e-cigarette users conducted in October by research firm ECigIntelligence found that Geekvape and Lost Mary were the two most popular brands, with Elf Bar not far behind. Zhang’s wealth has risen in step, to the point that he’s now worth $2.9 billion, according to the Bloomberg Billionaires Index, which calculated his net worth for the first time for this story. )

 

The success of Heaven Gifts is credited to its keen market insight and flexible response to regulations. The company specializes in disposable e-cigarettes, offering a wide variety of flavors at affordable prices to attract consumers, particularly in the European and American markets. However, the company also faces regulatory challenges. In the US, it has been accused of ignoring FDA regulations to profit from regulatory loopholes, while in the UK, Elf Bar has faced criticism for illegal products and false advertising. The article mentioned that Heaven Gifts' strategy includes splitting brands (such as Funky Lands, EB Create) to evade regulations and establishing a production base in Shenzhen to supply the global market. 

 

The article also highlighted competition from major tobacco companies and an investigation by the US International Trade Commission that Heaven Gifts is facing. Nevertheless, Trump's promise to "save e-cigarettes" may provide some breathing room for the company, although his specific policies are still unclear. A spokesperson for Heaven Gifts was interviewed for the article, stating that the company is withdrawing from the US market and aiming to expand its business in Europe. However, the article noted that their products are still circulating in the US, indicating that compliance commitments have not been fully met.

 

The above is compiled based on the English content. Please refer to the original English text for accuracy. (Read the original article)

 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Ireland’s Tobacco and Vape Retail Licensing Regime Takes Effect; BAT Says It Should Cover Nicotine Pouches
Ireland’s Tobacco and Vape Retail Licensing Regime Takes Effect; BAT Says It Should Cover Nicotine Pouches
Ireland’s retail licensing system took effect on Feb. 2, 2026, charging annual fees per point of sale and enforced by the Health Service Executive (HSE). British American Tobacco’s local unit, BAT Ireland, said excluding nicotine pouches could leave a regulatory gap.
Feb.04 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Product | OXVA launches SlimStick X in Europe and the U.S., shifting from pre-filled to open-system refilling
Product | OXVA launches SlimStick X in Europe and the U.S., shifting from pre-filled to open-system refilling
OXVA has recently launched its new e-cigarette, the SlimStick X. Unlike its predecessor, the SlimStick, which used a pre-filled pod system, the SlimStick X adopts an open-system refillable design, featuring a 2ml pod, a 1.0Ω coil, and a 1400mAh battery. The product has entered online retail channels in markets including the United States, the United Kingdom, Greece, and Spain, with a price of about $23.99.
Mar.06 by 2FIRSTS.ai
Philip Morris Ukraine Says Ukraine’s Flavored Vape Ban Still Lacks Effective Enforcement
Philip Morris Ukraine Says Ukraine’s Flavored Vape Ban Still Lacks Effective Enforcement
Mikhail Polyakov, deputy general director for corporate affairs at Philip Morris Ukraine, said Ukraine’s ban on flavored and aromatic additives for e-cigarettes, in force since July 11, 2024, has not worked in practice because compliance is not being enforced.
Mar.17 by 2FIRSTS.ai
Product | Refillable up to 30 mL in total and claimed 60,000 puffs: MASKKING launches open-system UCEE MAX
Product | Refillable up to 30 mL in total and claimed 60,000 puffs: MASKKING launches open-system UCEE MAX
E-cigarette brand MASKKING has recently listed its new UCEE MAX on its official website. According to the website, the device features an open, refillable design with a stated 10 mL e-liquid capacity, supports three refills, and claims a total of 60,000 puffs.
Mar.02 by 2FIRSTS.ai
22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap
22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap
22nd Century Group (Nasdaq: XXII) reported early commercial momentum for its FDA-authorized VLN® very low nicotine cigarettes, distributing approximately 8,800 cartons across 1,700 new U.S. retail outlets in the fourth quarter of 2025, while forecasting expansion to more than 5,000 retail points in 2026.
Business
Feb.24